Infectious Disease | Physician's Weekly
Advertisement

Infectious Disease

High Infection Secondary Attack Rates of Severe Acute Respiratory Syndrome Coronavirus 2 in Dutch Households Revealed by Dense Sampling

Jan 28, 2022

Main setting for transmission of severe acute respiratory syndrome coronavirus 2 is referred to the indoor environments. Households in a close contact environment results in high probability of transm...

Evaluation of Secondary Household Attack Rates for Emergent Spike L452R Drastic Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants Detected by Genomic Surveillance at a Community-Based Testing Site in San Francisco

Jan 28, 2022

An important epidemiological tool for just bonding to pandemics and monitoring is the sequencing of severe acute respiratory syndrome coronavirus 2 viral genome.  The generation of coronavirus 2 geno...

A case-control study about real-world experience of Bamlanivimab for coronavirus disease 2019.

Jan 28, 2022

COVID-19 has resulted in inpatient hospitalizations and death. Anti-spike monoclonal antibodies, including bamlanivimab, have resulted in a reduction in hospitalization rates in clinical trials. A stu...

The Impact of In-Person Primary and Secondary School Instruction on County-Level Severe Acute Respiratory Syndrome Coronavirus 2 expand in Indiana

Jan 28, 2022

Few studies aimed to determine the county-level effect of in-person primary and secondary school reopening on daily cases of severe acute respiratory syndrome coronavirus 2 in Indiana. For the followi...

Study of 189 cases of Neonatal Listeriosis Presentation and outcome

Jan 28, 2022

Listeria monocytogenes is a well borne pathogen that is responsible for Listeriosis. It is a maternal- neonatal infection. Researchers executed a nationwide analysis of features associated with neonat...

Disclosure and transmission of Daptomycin and Vancomycin-Resistant Enterococci between patients and hospital rooms

Jan 28, 2022

Vancomycin-resistant enterococci VRE is reported to be the major cause of morbidity and mortality in immunocompromised patients. It is crucial to understand the tracking of dissemination of VRE strain...

A Nationwide, Population-Based Study on Venous Thromboembolism and Major Bleeding in Patients With Coronavirus Disease 2019.

Jan 28, 2022

Certainly, a fatal complication of severe acute respiratory syndrome coronavirus through infection is venous thromboembolism. Thromboprophylaxis should be balanced against the risk of bleeding, and he...

Development of Vaccine for Meddling Infections told by Level Genomic Escherichia coli and Klebsiella pneumoniae Serotype Surveillance

Jan 28, 2022

In recent times, an increase in the bloodstream cases of bloodstream infections (BSIs) has been reported, caused by Escherichia coli and Klebsiella pneumonia. Researchers conducted a population-level ...

Study on the effect of Coronavirus Disease 2019 (COVID-19) Vaccination on its upsurge in the United States

Jan 28, 2022

Global vaccine development efforts were accelerated in response to the damaging coronavirus disease 2019 (COVID-19) pandemic. A study evaluated the impact of a 2-dose COVID-19 vaccination campaign on ...

Comparison of Coronavirus disease (COVID-19) with Influenza in Hospitalized Aged Patients in the United States: Demographic and Severity Indicator variances

Jan 28, 2022

Novel coronavirus disease 2019 (COVID-19) was commonly compared with influenza. The Hospitalized Adult Influenza Vaccine Effectiveness Network (HAIVEN) conducted the study on the etiology and characte...

Plasma Metabolomic Profiling of Patients Recovered From Coronavirus Disease 2019 (COVID-19) With Pulmonary Sequelae 3 Months After Discharge

Jan 28, 2022

Illumination of the molecular mechanisms involved in the pathogenesis of coronavirus disease 2019 (COVID-19) helped to discover therapeutic targets. To determine the metabolomic profile of circulating...

Clinical and Laboratory Findings in Patients With Potential Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Reinfection

Jan 28, 2022

A few studies explored patients with potential severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reinfection in the United States during May–July 2020. The researchers conducted case find...

Recommendations Simplified for Pneumococcal Vaccination

Jan 28, 2022

THURSDAY, Jan. 27, 2022 (HealthDay News) -- A new policy has simplified the Advisory Committee on Immunization Practices (ACIP) pneumococcal vaccination recommendations; the updated recommendations ar...

Risk for Early-Onset Sepsis Low for Infants With Low-Risk Delivery

Jan 27, 2022

WEDNESDAY, Jan. 26, 2022 (HealthDay News) -- Infants born at all gestational ages with low-risk delivery characteristics have a low risk for early-onset sepsis (EOS) and may not require initiation of ...

Adverse Events Among Young Adults After a Third Dose of Measles-Mumps-Rubella Vaccine

Jan 27, 2022

In the United States, a third measles-mumps-rubella (MMR) dose (MMR3) is suggested for people at higher risk for mumps during epidemics. MMR3 is also likely to be given to people who may have gotten t...

Three Weeks Versus Six Weeks of Antibiotic Therapy for Diabetic Foot Osteomyelitis: A Prospective, Randomised, Noninferiority Pilot Trial

Jan 27, 2022

Researchers looked at whether a short (3 weeks) or a long (6 weeks) period of systemic antibiotic treatment is linked with non-inferior clinical remission and adverse events in diabetic foot osteomyel...

Clinical and Virological Characteristics of a Cluster of Five Paediatric Cases with Acute Eosinophilic Lymphadenitis-like Illness Associated with Human Adenovirus 7

Jan 27, 2022

Immune dysregulation, known as hemophagocytic lymphohistiocytosis (HLH), is a life-threatening illness. Primary genetic types of HLH, which can be induced by infection, are common in children. Others ...

A Phase 2 Study of VT-1161 for the Treatment of Early-Stage Vulvovaginal Candidiasis Was Conducted as a Randomised Double-blind Placebo-Controlled Trial

Jan 27, 2022

Although acute vulvovaginal candidiasis (VVC) is common in women, current azole antifungal therapies are frequently linked to safety and resistance concerns. The oral drug VT-1161 (oteseconazole) has ...

A Phase 3, Randomised, Double-blind Trial (TARGET) Ceftobiprole Compared With Vancomycin Plus Aztreonam In The Treatment of Acute Bacterial and Skin Structure Infections

Jan 27, 2022

Development of new broad-spectrum antibiotics that are effective against both gram-positive and gram-negative bacteria could improve treatment choices for bacterial skin and skin structure infections ...

Impact of a Consensus-based Process versus Systematic Reviews on the Recommendations for the Treatment of Community-Acquired Pneumonia

Jan 27, 2022

The Community-acquired Pneumonia (CAP) guidelines from the American Thoracic Society (ATS) and the Infectious Diseases Society of America (IDSA) were established utilizing systematic reviews to inform...